Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04127513Phase 3Completed
Phase 3, randomised, double-blind trial of ammonium lactate in xerosis cutis (2 arms), sponsored by Universitas Indonesia. Primary endpoints: Specified Symptom Sum Score at Day 36, Skin Capacitance at Day 36 and 2 more. Started Apr 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04127513.